Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
42 Leser
Artikel bewerten:
(0)

Global Medical Aesthetics Industry: Cosmetic Surgery Products Generated $8.8 Billion in 2016 & Have the Potential to Reach $15.3 Billion in 2022

DUBLIN, July 28, 2017 /PRNewswire/ --

The "Global Medical Aesthetics Industry: Injectables, Energy-Based Devices, Cosmeceuticals, Cosmetic Surgery, Facial Aesthetics, Implants, Cosmetic Tourism. Market Analysis & Forecast to 2022" report has been added to Research and Markets' offering.

Research and Markets Logo

This analysis indicates that the current medical aesthetic industry is worth $53.3 billion for both service and product revenue. Over the next five years a CAGR of 5.5% is expected and the market will hit $73.6 billion in 2022.

Currently, invasive aesthetic procedures generate revenues of over $27.8 billion, annually. The analysis indicate that by 2022, invasive aesthetic procedures will grow at a CAGR of 4.3%. Non-invasive procedures generate approximately $16.7 billion per annum and will grow at a CAGR of 4.5% over the coming five years. Cosmetic surgery products generated $8.8 billion in 2016 and have the potential to reach $15.3 billion in 2022.

The North American market accounts for about 45% of the global market. However, the dominance of the U.S. is shifting towards Asia, particularly in the energy- based devices segment. Asia is regarded as the next frontier and the number of physicians and clinics in China and India has been steadily rising, along with medical tourism in the region. In the injectables and devices category, the E.U. occupies the second position behind the U.S. Brazil continues to be a strong market for aesthetics and cosmetic procedures. The Russian market is also experiencing fast growth compared to many E.U. countries and the Russian market is particularly strong for devices and topicals.

Companies Mentioned

  • Aerolase Corp.
  • Adoderm GmbH
  • Aesthetic Dermal S.L.
  • Allergan Inc.
  • Allied Biomedical
  • Alma Lasers Ltd.
  • Amiea Med
  • Andrew Technologies LLC
  • Anika Therapeutics Inc.
  • Anteis S.A.
  • Apira Science Inc.
  • Aqtis Medical B.V.
  • Baby Quasar
  • Benev Company
  • Biopelle Inc.
  • Biotechnique Avance
  • Breit Aesthetics Ltd.
  • BTL Industries Inc.
  • Canfield Imaging Systems
  • Carol Cole Co.
  • (80+ Others)

Key Topics Covered:

1.0 Introduction

2.0 Surgical Cosmetic Procedures: An Overview

3.0 Nonsurgical Cosmetic Procedures: An Overview

4.0 Physician Dispensed Cosmeceuticals: An Overview

5.0 Cosmetic Surgery Products and Technologies: An Overview

6.0 Energy-Based Technologies for Cosmetic Procedures: An Overview

7.0 Emerging Technologies in the Aesthetic Sector

8.0 Current Clinical Trials for Aging Skin

9.0 Market Analysis & Forecast Through 2022

10.0 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/k95tmr/global_medical

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.